Infectious vaginitis

Preview

Until recently, vaginal candidiasis was generally managed with topical preparations, whereas trichomoniasis and bacterial vaginosis required systemic therapy. Now both topical and systemic therapies are available for vaginal candidiasis and bacterial vaginosis, although systemic therapy is still recommended for trichomoniasis. This article reviews considerations in selecting the most appropriate therapy, including drug efficacy, history of recurrence, ease of administration, and cost.

Additional information

Notes on contributors

Michelle A. Goode

Michelle A. Goode, PharmD Dr Goode is clinical assistant professor/clinical specialist, department of hospital pharmacy practice and administration, Medical University of South Carolina, Charleston.

Ken Grauer

Ken Grauer, MD Dr Grauer is professor, department of community health and family medicine, and assistant director, family medicine residency program, University of Florida College of Medicine, Gainesville.

John G. Gums

John G. Gums, PharmD Dr Gums is associate professor of pharmacy and medicine, department of community health and family medicine and department of pharmacy practice, University of Florida College of Medicine, Gainesville.